Dr. Agarwal’s Health Care Limited has received the compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2025. This certificate confirms that all securities dematerialized/rematerialized during the quarter have been duly processed and that the information has been furnished to all stock exchanges where the company’s shares are listed.
Compliance Confirmation
Dr. Agarwal’s Health Care Limited confirms receipt of the compliance certificate pertaining to the handling of dematerialized and rematerialized securities. The certificate, as mandated by regulatory requirements, covers the period ending September 30, 2025.
Details of the Certificate
The certificate, issued by KFin Technologies Limited, the Registrar and Share Transfer Agent, ensures adherence to proper procedures for all transactions involving the company’s securities. This compliance is a mandatory part of maintaining transparency and regulatory integrity for listed entities.
Official Communication
The company has formally submitted the certificate to both the BSE Limited and the National Stock Exchange of India Limited on October 03, 2025, ensuring prompt dissemination of information to stakeholders and compliance with listing requirements.
Source: BSE
